Juan Carlos
Martínez Castrillo
Profesor/a Asociado/a en CC. de la Salud
Hospital Universitario La Fe
Valencia, EspañaPublicacions en col·laboració amb investigadors/es de Hospital Universitario La Fe (19)
2023
-
Staging Parkinson's Disease According to the MNCD (Motor/Non-motor/Cognition/Dependency) Classification Correlates with Disease Severity and Quality of Life
Journal of Parkinson's disease, Vol. 13, Núm. 3, pp. 379-402
2021
-
Management of Parkinson's disease and other movement disorders in woman of childbearing age: Part 1
Neurologia, Vol. 36, Núm. 2, pp. 149-158
-
Management of Parkinson's disease and other movement disorders in women of childbearing age: Part 2
Neurologia, Vol. 36, Núm. 2, pp. 159-168
-
Mutational spectrum of GNAL, THAP1 and TOR1A genes in isolated dystonia: study in a population from Spain and systematic literature review
European Journal of Neurology, Vol. 28, Núm. 4, pp. 1188-1197
-
Opicapone for the treatment of Parkinson’s disease: real-life data in Spain
Revista de Neurologia, Vol. 73, pp. S1-S14
2019
-
Transcranial sonography in atypical parkinsonism: How reliable is it in real clinical practice? A multicentre comprehensive study
Parkinsonism and Related Disorders, Vol. 68, pp. 40-45
2018
-
Behavioral addictions in early-onset Parkinson disease are associated with DRD3 variants
Parkinsonism and Related Disorders, Vol. 49, pp. 100-103
-
Mitos y evidencias en el empleo de la toxina botulínica: Neurofarmacología y distonías
Revista de Neurologia, Vol. 66, Núm. 5, pp. 163-172
2016
2014
-
BDNF Val66Met polymorphism in primary adult-onset dystonia: A case-control study and meta-analysis
Movement Disorders, Vol. 29, Núm. 8, pp. 1083-1086
-
Lack of validation of variants associated with cervical dystonia risk: A GWAS replication study
Movement Disorders, Vol. 29, Núm. 14, pp. 1825-1828
2013
-
Advanced Parkinson's disease: Clinical characteristics and treatment (part 1)
Neurologia, Vol. 28, Núm. 8, pp. 503-521
-
Enfermedad de Parkinson avanzada. Características clínicas y tratamiento. Parte II
Neurologia, Vol. 28, Núm. 9, pp. 558-583
2012
-
levodopa en el tratamiento de la enfermedad de parkinson: Mitos y realidades
Revista de Neurologia, Vol. 55, Núm. 11, pp. 669-688
2011
-
Evolution of dose and response to botulinum toxin A in cervical dystonia: A multicenter study
Journal of Neurology, Vol. 258, Núm. 6, pp. 1055-1057
2008
-
Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: A multicenter study
Movement Disorders, Vol. 23, Núm. 8, pp. 1130-1136
2006
-
A longitudinal study of patients with Parkinson's disease (ELEP): Aims and methodology
Revista de Neurologia, Vol. 42, Núm. 6, pp. 360-365
-
Creación y protocolo de seguimiento longitudinal de una cohorte multipropósito de pacientes con enfermedad de Parkinson de reciente diagnóstico: Proyecto VIP
Revista de Neurologia, Vol. 43, Núm. 6, pp. 366-373
-
Global versus factor-related impression of severity in Parkinson's disease: A new clinimetric index (CISI-PD)
Movement Disorders, Vol. 21, Núm. 2, pp. 208-214